Recce (ASX:RCE) share price edges lower following study delays
The Recce Pharmaceuticals Ltd(ASX: RCE) share price is falling after the company released an update on its clinical pipeline. In afternoon trade, shares in Recce Pharmaceuticals are trading 0.46% lower at $1.08.
The update announced delays to the company’s…
